Úlcera digital como manifestación inicial de esclerodermia sistémica cutánea limitada
Palabras clave:
úlcera digital, anticuerpos anticentrómero, esclerodermia. Digital ulcer, anticentromere antibodies, scleroderma
Resumen
Se presenta el caso de una paciente de 68 años que presentó una úlcera digital como manifestación inicial de esclerodermia sistémica limitada. Es un caso demostrativo que resalta la importancia de la intervención del dermatólogo mediante una adecuada historia clínica, examen físico, tamización y correlación clínico-patológica, para obtener un diagnóstico temprano y establecer el tratamiento oportuno en estos pacientes.
Referencias bibliográficas
1. Balbir-Gurman, Moscovici Scleroderma: New aspects in pathogenesis and treatment. Best Pract Res Clin Rheumatol. 2012;26:13-24.
2. Grossman C, Dovrish Z, Shoenfeld Y, Amital H. Do infections facilitate the emergence of systemic sclerosis? Autoimmun Rev. 2011;10:244-7.
3. Arora-Singh RK, Assassi S, del Junco DJ, Arnett FC, Perry M, Irfan U. Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. J Autoimmun. 2010;35:52-7.
4. Avouac, Fransen, Walker, Riccieri, Smith. Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis. 2011;70:476-81.
5. Sachsenberg-Studer, Salomon, Prins, Saurat. Raynaud’s phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: An entity independent of scleroderma? J Am Acad Dermatol. 2000;43:631-4.
6. Vayssairat M, Baudot N, Gaitz JP. Raynaud’s phenomenon together with antinuclear antibodies: A common subset of incomplete connective tissue disease. J Am Acad Dermatol. 1995;32:747-9.
7. Vayssairat M, Abuaf N, Baudot N, Deschamps A, Gaitz JP. Abnormal IgG cardiolipin antibody titers in patients with Raynaud’s phenomenon and/or related disorders: Prevalence and clinical significance. J Am Acad Dermatol. 1998;38:555
2. Grossman C, Dovrish Z, Shoenfeld Y, Amital H. Do infections facilitate the emergence of systemic sclerosis? Autoimmun Rev. 2011;10:244-7.
3. Arora-Singh RK, Assassi S, del Junco DJ, Arnett FC, Perry M, Irfan U. Autoimmune diseases and autoantibodies in the first degree relatives of patients with systemic sclerosis. J Autoimmun. 2010;35:52-7.
4. Avouac, Fransen, Walker, Riccieri, Smith. Preliminary criteria for the very early diagnosis of systemic sclerosis: Results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group. Ann Rheum Dis. 2011;70:476-81.
5. Sachsenberg-Studer, Salomon, Prins, Saurat. Raynaud’s phenomenon, anticentromere antibodies, and digital necrosis without sclerodactyly: An entity independent of scleroderma? J Am Acad Dermatol. 2000;43:631-4.
6. Vayssairat M, Baudot N, Gaitz JP. Raynaud’s phenomenon together with antinuclear antibodies: A common subset of incomplete connective tissue disease. J Am Acad Dermatol. 1995;32:747-9.
7. Vayssairat M, Abuaf N, Baudot N, Deschamps A, Gaitz JP. Abnormal IgG cardiolipin antibody titers in patients with Raynaud’s phenomenon and/or related disorders: Prevalence and clinical significance. J Am Acad Dermatol. 1998;38:555
Cómo citar
1.
Arenas CM, Jiménez J, González MI. Úlcera digital como manifestación inicial de esclerodermia sistémica cutánea limitada. rev. asoc. colomb. dermatol. cir. dematol. [Internet]. 9 de agosto de 2019 [citado 6 de diciembre de 2022];21(4):360-3. Disponible en: https://revista.asocolderma.org.co/index.php/asocolderma/article/view/1029
Descargas
Los datos de descargas todavía no están disponibles.
